Clinical impact of molecular subtyping of pancreatic cancer (vol 9, 743908, 2021)

被引：0
|
作者：
Zhou, Xu [1 ,2 ]
Hu, Kai [1 ,2 ]
Bailey, Peter [1 ,2 ,3 ]
Springfeld, Christoph [4 ]
Roth, Susanne [1 ]
Kurilov, Roma [5 ]
Brors, Benedikt [4 ,5 ]
Gress, Thomas [6 ]
Buchholz, Malte [6 ]
An, Jingyu [1 ,2 ]
Wei, Kongyuan [1 ,2 ]
Peccerella, Teresa [1 ,2 ]
Buechler, Markus W. [1 ]
Hackert, Thilo [1 ]
Neoptolemos, John P. [1 ,2 ]
机构：
[1] Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[2] Heidelberg Univ Hosp, Sect Surg Res, Heidelberg, Germany
[3] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland
[4] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany
[5] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany
[6] Philipps Univ Marburg, Dept Gastroenterol & Endocrinol, Marburg, Germany
来源：
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2023年 / 11卷
关键词：
molecular subtypes; transcriptomes; structural variants; precision medicine; next generation sequencing; clinical trials; ESPAC;
D O I：
10.3389/fcell.2023.1179559
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical Impact of Molecular Subtyping of Pancreatic Cancer
    Xu, Zhou
    Hu, Kai
    Bailey, Peter
    Springfeld, Christoph
    Roth, Susanne
    Kurilov, Roma
    Brors, Benedikt
    Gress, Thomas
    Buchholz, Malte
    An, Jingyu
    Wei, Kongyuan
    Peccerella, Teresa
    Buechler, Markus W.
    Hackert, Thilo
    Neoptolemos, John P.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [2] The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer
    Dreyer, Stephan B.
    Rae, Sarah
    Bisset, Kirsty
    Upstill-Goddard, Rosie
    Gemenetzis, Georgios
    Johns, Amber L.
    Dickson, Euan J.
    Mittal, Anubhav
    Gill, Anthony
    Duthie, Fraser T.
    Pea, Antonio
    Lawlor, Rita
    Scarpa, Aldo
    Salvia, Roberto
    Pulvirenti, Alessandra
    Zerbi, Alessandro J.
    Marchesi, Federica V.
    McKay, Colin S.
    Biankin, Andrew K.
    Samra, Jaswinder B.
    Chang, David K.
    Jamieson, Nigel
    ANNALS OF SURGERY, 2023, 277 (02) : E396 - E405
  • [3] Molecular Subtyping and Precision Medicine for Pancreatic Cancer
    Froeling, Fieke E. M.
    Casolino, Raffaella
    Pea, Antonio
    Biankin, Andrew V.
    Chang, David K.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 13
  • [4] Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer
    Pishvaian, Michael J.
    Brody, Jonathan R.
    ONCOLOGY-NEW YORK, 2017, 31 (03): : 159 - 168
  • [5] Clinical implications of molecular subtyping in bladder cancer
    Satyal, Uttam
    Sikder, Rahmat K.
    McConkey, David
    Plimack, Elizabeth R.
    Abbosh, Philip H.
    CURRENT OPINION IN UROLOGY, 2019, 29 (04) : 350 - 356
  • [6] Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic
    Du, Yongxing
    Zhao, Bangbo
    Liu, Ziwen
    Ren, Xiaoxia
    Zhao, Wenjing
    Li, Zongze
    You, Lei
    Zhao, Yupei
    JOURNAL OF CANCER, 2017, 8 (04): : 513 - 522
  • [7] Distinctions with a Difference: RNA Subtyping and Clinical Outcome in Pancreatic Cancer
    Collisson, Eric A.
    CLINICAL CANCER RESEARCH, 2020, 26 (18) : 4715 - 4716
  • [8] Molecular subtyping bladder cancer: Is it ready for clinical practice?
    Lopez, Funda Vakar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 1677 - 1678
  • [9] Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
    Liu, Jingkai
    Liu, Qiaofei
    Zhang, Xiang
    Cui, Ming
    Li, Tong
    Zhang, Yalu
    Liao, Quan
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [10] Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
    Jingkai Liu
    Qiaofei Liu
    Xiang Zhang
    Ming Cui
    Tong Li
    Yalu Zhang
    Quan Liao
    Cancer Cell International, 21
12345